ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc.（ANIP）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ANIP · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
55
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
ANI Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ANIP 季度内部人买卖趋势
ANIP 内幕交易卖出 · ANIP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ANIP CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ANIP 高管卖出股份 · ANIP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 11, 2026 | Walsh Patrick D Director | Sale | 3,973 | $321K | Form 4 |
| May 13, 2026 | Walsh Patrick D Director | Sale | 10,000 | $806K | Form 4 |
| May 12, 2026 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Sale | 459 | $36K | Form 4 |
| May 11, 2026 | Lalwani Nikhil PRESIDENT & CEO · Director | Sale | 55,000 | $4.27M⚡ | Form 4 |
| May 12, 2026 | Gutwerg Ori SVP, GENERICS | Sale | 2,772 | $220K | Form 4 |
| May 13, 2026 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $39K | Form 4 |
| Apr 13, 2026 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $39K | Form 4 |
| Mar 11, 2026 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Sale | 4,772 | $357K | Form 4 |
| Mar 13, 2026 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 3,162 | $227K | Form 4 |
| Mar 13, 2026 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $36K | Form 4 |
| Mar 6, 2026 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 2,121 | $157K | Form 4 |
| Mar 7, 2026 | Mutz Christopher HEAD OF RARE DISEASE | Other | 3,314 | $245K | Form 4 |
| Mar 9, 2026 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 3,602 | $267K | Form 4 |
| Mar 7, 2026 | Lalwani Nikhil PRESIDENT & CEO · Director | Other | 17,060 | $1.26M⚡ | Form 4 |
| Mar 7, 2026 | Gutwerg Ori SVP, GENERICS | Other | 3,314 | $245K | Form 4 |
| Mar 6, 2026 | Davis Krista SVP, CHIEF HR OFFICER | Sale | 1,485 | $111K | Form 4 |
| Mar 9, 2026 | Davis Krista SVP, CHIEF HR OFFICER | Sale | 5,087 | $377K | Form 4 |
| Mar 7, 2026 | CAREY STEPHEN P. SVP & CFO | Other | 5,150 | $381K | Form 4 |
| Mar 5, 2026 | CAREY STEPHEN P. SVP & CFO | Option | 3,312 | $164K | Form 4 |
| Mar 5, 2026 | CAREY STEPHEN P. SVP & CFO | Sale | 3,312 | $250K | Form 4 |
| Mar 5, 2026 | CAREY STEPHEN P. SVP & CFO | Sale | 4,000 | $302K | Form 4 |
| Mar 2, 2026 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 417 | $31K | Form 4 |
| Mar 3, 2026 | Gutwerg Ori SVP, GENERICS | Sale | 2,060 | $158K | Form 4 |
| Mar 3, 2026 | Walsh Patrick D Director | Sale | 6,000 | $445K | Form 4 |
| Feb 26, 2026 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · Director | Award | 11,116 | $858K | Form 4 |
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
日期
May 12
股数
459
均价
$79.21
总金额
$36K
Lalwani Nikhil
PRESIDENT & CEO · Director
日期
May 11
股数
55,000
均价
$77.57
总金额
$4.27M ⚡
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
日期
Mar 11
股数
4,772
均价
$74.91
总金额
$357K
Lalwani Nikhil
PRESIDENT & CEO · Director
日期
Mar 7
股数
17,060
均价
$74.04
总金额
$1.26M ⚡
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS · Director
日期
Feb 26
股数
11,116
均价
$77.15
总金额
$858K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ANIP 内幕交易
ANIP 内幕交易
ANI Pharmaceuticals, Inc.（ANIP）内幕交易数据来源于公司内部人（包括Cook Meredith (SR. VP, GENERAL COUNSEL & SEC.), Davis Krista (SVP, CHIEF HR OFFICER), Mutz Christopher (HEAD OF RARE DISEASE)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ANIP内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ANI Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ANIP 内幕交易 · 5个问题ANI Pharmaceuticals, Inc.（ANIP）的内部人包括高管和董事，如Cook Meredith (SR. VP, GENERAL COUNSEL & SEC.), Davis Krista (SVP, CHIEF HR OFFICER), Mutz Christopher (HEAD OF RARE DISEASE)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026